Sat.Aug 21, 2021 - Fri.Aug 27, 2021

Remove covid-19
article thumbnail

5 Ways Marketing Changed with COVID-19 that Affect Cannabis Businesses – Cannabis Business Executive

SpeedWeed

5 Ways Marketing Changed with COVID-19 that Affect Cannabis Businesses – Cannabis Business Executive – Cannabis and Marijuana industry news. The post 5 Ways Marketing Changed with COVID-19 that Affect Cannabis Businesses – Cannabis Business Executive appeared first on SpeedWeed.

article thumbnail

FSD Pharma Inc. Announces Termination of FSD-201 Phase 2 Clinical Trial

Cannabis Law Report

(Nasdaq:HUGE) (CSE:HUGE) (FRA:0K9) (the “ Company ” or “ FSD ”) announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide (“PEA”), or FSD-201, for use in treating COVID-19. The Company is working to complete and publish these findings in the near future.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Rapid Dose Therapeutics Reports Fiscal Year 2021 Financial Results

Cannabis Law Report

“Momentum is building, and we are pleased to see sales growth in our key business lines including cannabis and nutraceuticals with rapid movement with our partners at McMaster University on the COVID-19 vaccine candidate.”. 2021 Financial Information: Fiscal Year. . February 28, 2021. February 29, 2020. 159%. . . . 2,477,065).

article thumbnail

Zoned Properties Announces Completion of $8 Million Expansion at Its Chino Valley Cultivation Facility

Cannabis Law Report

COVID-19 Statement. In March 2020, the World Health Organization declared COVID-19 a global pandemic and recommended containment and mitigation measures worldwide. We did not experience in 2020, and to date have not experienced in 2021, any material changes to our operations from COVID-19.

article thumbnail

Rapid Dose Therapeutics Reports Q1 Financial Results and Exercise of Warrant for Net Proceeds of $689,000

Cannabis Law Report

We are well positioned to have a number of exciting COVID-19 vaccine announcements to come with the results from the ongoing McMaster University studies and the launch of our RDT-branded cannabis products on store shelves, among others.

Events 111
article thumbnail

MyMD Pharmaceuticals Announces Issuance of U.S. Patent for Use of Lead Candidate MYMD-1 for Treating Fibrosis and Asthma

Cannabis Law Report

MYMD-1 is being developed to treat aging and longevity, autoimmune diseases, and COVID-19- associated depression and cytokine elevation. MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immunometabolic system to control TNF-?,

article thumbnail

Trulieve Announces Opening of 100th Dispensary in United States

Cannabis Law Report

Trulieve continues to monitor the COVID-19 situation and remains committed to slowing the spread in our communities. Appointments can be made on Trulieve’s website and are open to all patients, whether starting their journey with medical cannabis or those with experience looking for alternative treatment options.